跳至主要内容
临床试验/NCT05514028
NCT05514028招募中不适用

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin - OVAmiARN Study

ZIWIG12 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2022年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
ZIWIG
入组人数
250
试验地点
12
主要终点
Area under the curve (AUC) of the Receiver Operating Curve (ROC)

研究概览

简要总结

OVAmiARN is a multicentre, prospective, longitudinal, non-interventional, observational study carried out in 8 obstetrics and gynecology departments in France; in order to describe the evolution of salivary miRNA expression between the pre-operative and post-therapy visits according to the type of mass. In time, the clinical application will be to significantly reduce the time to diagnosis and improve the care pathway for ovarian adnexal mass.

The study population consists of patients with an ovarian adnexal mass diagnosed by clinical examination and imaging (pelvic ultrasound and/or MRI) and requiring surgical management in routine care.

The patients concerned by the study will be managed without modification of the care pathway, nor modification of the therapeutic indications, nor modification of the diagnostic or follow-up examinations (imaging or biology) necessary according to the context, which are carried out according to the recommendations of the HAS, CNGOF.

In this study, the management and follow-up of patients :

  • Are not imposed by the study: the doctor remains free to make medical prescriptions (treatments and examinations) and to determine the interval between consultation visits,
  • Are not modified in comparison with the usual follow-up, except for the performance of the Collection of saliva

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient over 18 years of age,
  • A patient with an ovarian adnexal mass diagnosed by clinical examination and imaging and likely to be ovarian cancer, a borderline tumour or a benign cyst,
  • Patient with an indication for surgery
  • Patient has dated and signed the consent form,
  • Patient affiliated to the healthcare system,

排除标准

  • Pregnant patient
  • Patient infected with human immunodeficiency virus (HIV),
  • Patient with significant difficulties in reading or writing the French language.
  • Patient with another diagnosed cancer
  • Patient with a history of cancer less than 5 years old

结局指标

主要结局

Area under the curve (AUC) of the Receiver Operating Curve (ROC)

时间窗: Through the end of study inclusions, an average of 6 months

Identifying a signature of ovarian cancer diagnosis by analysis of coding and non-coding RNAs in the saliva of subjects

次要结局

未报告次要终点

研究者

发起方
ZIWIG
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验